Vivus Inc (VVUS):企業の財務・戦略的SWOT分析

◆英語タイトル:Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1653
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vivus Inc (VVUS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vivus Inc (Vivus) is a biopharmaceutical company that develops and commercializes next-generation therapeutics for addressing unmet medical needs of obesity, sleep apnea, diabetes, and sexual health. The company markets phentermine and topiramate extended-release capsules for the chronic weight management in adult patients; avanafil, an oral phosphodiesterase type 5, for erectile dysfunction; and pancrelipase microtablets for exocrine pancreatic insufficiency. It is investigating its pipeline products for the treatment of obstructive sleep apnea, nonalcoholic steatohepatitis, diabetes, and pulmonary arterial hypertension. Vivus works in partnership with pharmaceutical companies to advance of its product and pipeline portfolio. The company also has direct operations through its subsidiaries in Canada and the Netherlands. Vivus is headquartered in Campbell, California, the US.

Vivus Inc Key Recent Developments

Apr 03,2020 VitalTech partners with VIVUS Pharmaceuticals to accelerate launch of telehealth and remote patient monitoring modules
Apr 01,2020 VIVUS announces $11.55 million registered direct offering priced at-the-market under Nasdaq Rules
Mar 31,2020 VIVUS accelerates the launch of telemedicine and remote monitoring modules to facilitate effective patient care during “social distancing”
Mar 03,2020 VIVUS reports fourth quarter and full year 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vivus Inc – Key Facts
Vivus Inc – Key Employees
Vivus Inc – Key Employee Biographies
Vivus Inc – Major Products and Services
Vivus Inc – History
Vivus Inc – Company Statement
Vivus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vivus Inc – Business Description
Product Category: License and Milestone Revenue
Performance
Product Category: Pancreaze/ Pancreaze MT (Net Product and Royalty Revenue)
Performance
Product Category: Qsymia (Net Product and Supply Revenue)
Performance
Product Category: Stendra/Spedra (Supply and Royalty Revenue)
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The US
Performance
Vivus Inc – Corporate Strategy
Vivus Inc – SWOT Analysis
SWOT Analysis – Overview
Vivus Inc – Strengths
Vivus Inc – Weaknesses
Vivus Inc – Opportunities
Vivus Inc – Threats
Vivus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vivus Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 03, 2020: VitalTech partners with VIVUS Pharmaceuticals to accelerate launch of telehealth and remote patient monitoring modules
Apr 01, 2020: VIVUS announces $11.55 million registered direct offering priced at-the-market under Nasdaq Rules
Mar 31, 2020: VIVUS accelerates the launch of telemedicine and remote monitoring modules to facilitate effective patient care during “social distancing”
Mar 03, 2020: VIVUS reports fourth quarter and full year 2019 financial results
Nov 05, 2019: VIVUS reports third quarter 2019 financial results
Oct 28, 2019: VIVUS announces departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
Aug 06, 2019: VIVUS reports second quarter 2019 financial results
Apr 30, 2019: VIVUS Reports First Quarter 2019 Financial Results
Feb 26, 2019: VIVUS announces fourth quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vivus Inc, Key Facts
Vivus Inc, Key Employees
Vivus Inc, Key Employee Biographies
Vivus Inc, Major Products and Services
Vivus Inc, History
Vivus Inc, Subsidiaries
Vivus Inc, Key Competitors
Vivus Inc, Ratios based on current share price
Vivus Inc, Annual Ratios
Vivus Inc, Annual Ratios (Cont...1)
Vivus Inc, Annual Ratios (Cont...2)
Vivus Inc, Interim Ratios
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Vivus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Vivus Inc, Performance Chart (2015 - 2019)
Vivus Inc, Ratio Charts
Vivus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Vivus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Vivus Inc (VVUS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enel Green Power SpA:電力:M&Aディール及び事業提携情報
    Summary Enel Green Power SpA (EGP) a subsidiary of Enel SpA, is an energy company that is involved in developing and operating renewable projects. It generates power from wind, biomass, geothermal, solar, and hydropower sources. The company also has interests in various power plants in under constru …
  • Capital Power Corporation (CPX):電力:M&Aディール及び事業提携情報
    Summary Capital Power Corporation (CPC) is a power producer that develops, acquires, operates, optimizes, and builds power generation facilities. It generates electricity by harnessing energy-efficient technology from lower-carbon fuel, and a range of renewable energy sources. The company owns super …
  • EWE AG:企業の戦略的SWOT分析
    EWE AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Lincoln National Corporation:企業の戦略・SWOT・財務情報
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Crown Resorts Ltd:企業の戦略・SWOT・財務分析
    Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Crown Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Range Energy Resources Inc (RGO):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Energy Resources Inc (Range Energy), formerly Hawkstone Energy Corp, is an oil and gas company that offers exploration and development services. The company acquires, explores and produces minerals, and oil and gas resource properties. It holds interests in Khalakan Production Sharing …
  • Helix BioPharma Corp (HBP):企業の財務・戦略的SWOT分析
    Helix BioPharma Corp (HBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hindustan Unilever Limited:戦略・SWOT・企業財務分析
    Hindustan Unilever Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Unilever Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Angel Yeast Co Ltd:企業の戦略・SWOT・財務情報
    Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Angel Yeast Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mayo Clinic Health System in Eau Claire:企業の戦略的SWOT分析
    Mayo Clinic Health System in Eau Claire - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • First Bancorp. (FBP):企業の財務・戦略的SWOT分析
    First Bancorp. (FBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yue Yuen Industrial (Holdings) Limited:企業の戦略・SWOT・財務情報
    Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Yue Yuen Industrial (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Viesgo:電力:M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • Prospect Resources Limited:企業の戦略・SWOT・財務情報
    Prospect Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Prospect Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • M.M.Warburg & Co Kgaa:企業の戦略・SWOT・財務分析
    M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acceleron Pharma Inc (XLRN)-製薬・医療分野:企業M&A・提携分析
    Summary Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodyspla …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆